SEC Company Response from NORTHWEST BIOTHERAPEUTICS INC (NWBO) (CIK 0001072379) (NWBO) — Oct 29, 2019
NORTHWEST BIOTHERAPEUTICS INC (NWBO) (CIK 0001072379)
Date: Oct. 29, 2019 · CIK: 0001072379 · Accession: 0001104659-19-057265
AI Filing Summary & Sentiment
File numbers found in text: 333-234248
Show Raw Text
CORRESP 1 filename1.htm October 29, 2019 Via Edgar Only United States Securities and Exchange Commission Mail Stop 6010 Washington, D.C. 20549 Attention: Ms. Ada D. Sarmento SEC Division of Corporation Finance Re: Northwest Biotherapeutics, Inc. Registration Statement on Form S-3 Filed on October 18, 2019 File No. 333-234248 Dear Ms. Sarmento: Please be advised that the undersigned is the duly elected Chief Executive Officer of Northwest Biotherapeutics, Inc. (the "Registrant"). Having been advised that the Commission has no further comments to the Registrant's Form S-3 Registration Statement (File No. 333-234248), the Registrant hereby requests acceleration of the effective date of the Registration Statement on Thursday, October 31, 2019 at 4:00 p.m., or as soon thereafter as practicable. Should you have any questions in regard to this correspondence or any other matter relating to this Registrant’s filing, please do not hesitate to contact me. Very truly yours, /s/ Linda F. Powers Linda F. Powers